Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Finati

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The Prostate|March 11, 2025
Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized PCa in a North-American CohortSilvia Viganò, Marco Finati, Alex Stephens, et al.
Urologic Oncology|March 24, 2024
Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohortNicholas James Corsi, Alex Stephens, Marco Finati, et al.
Urology|December 31, 2023
Admission Rates, Healthcare Utilization, and Inpatient Cost of Radiation Cystitis in the United StatesSohrab Arora, Irene Chen, Chandler Bronkema, et al.
JNCI Cancer Spectrum|November 22, 2024
Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohortMarco Finati, Alex Stephens, Giuseppe Ottone Cirulli, et al.
European Urology Oncology|July 11, 2024
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American CohortMarco Finati, Matthew Davis, Alex Stephens, et al.
Urologic Oncology|September 6, 2024
Radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohortMarco Finati, Alex Stephens, Giuseppe Chiarelli, et al.
The Prostate|January 27, 2025
Comparing PSA Screening Patterns and Their Role as Predictor of Prostate Cancer Diagnosis: Analysis of a Contemporary North American CohortGiuseppe Ottone Cirulli, Alex Stephens, Giuseppe Chiarelli, et al.
Cancer|October 8, 2024
Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortalityGiuseppe Ottone Cirulli, Matthew Davis, Alex Stephens, et al.
BJU International|December 14, 2023
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysisGiuseppe Ottone Cirulli, Nicholas Corsi, Ivan Rakic, et al.
The Journal of Urology|July 30, 2024
Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort AnalysisGiuseppe Ottone Cirulli, Matthew Davis, Alex Stephens, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Prostate|March 11, 2025
Socioeconomic Disparities in Prostate Cancer Treatment: The Impact of Area Deprivation Index on Initial Treatment Type for Localized PCa in a North-American CohortSilvia Viganò, Marco Finati, Alex Stephens, et al.
Urologic Oncology|March 24, 2024
Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohortNicholas James Corsi, Alex Stephens, Marco Finati, et al.
Urology|December 31, 2023
Admission Rates, Healthcare Utilization, and Inpatient Cost of Radiation Cystitis in the United StatesSohrab Arora, Irene Chen, Chandler Bronkema, et al.
JNCI Cancer Spectrum|November 22, 2024
Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohortMarco Finati, Alex Stephens, Giuseppe Ottone Cirulli, et al.
European Urology Oncology|July 11, 2024
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American CohortMarco Finati, Matthew Davis, Alex Stephens, et al.
Urologic Oncology|September 6, 2024
Radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohortMarco Finati, Alex Stephens, Giuseppe Chiarelli, et al.
The Prostate|January 27, 2025
Comparing PSA Screening Patterns and Their Role as Predictor of Prostate Cancer Diagnosis: Analysis of a Contemporary North American CohortGiuseppe Ottone Cirulli, Alex Stephens, Giuseppe Chiarelli, et al.
Cancer|October 8, 2024
Midlife baseline prostate-specific antigen, velocity, and doubling time association with lethal prostate cancer and mortalityGiuseppe Ottone Cirulli, Matthew Davis, Alex Stephens, et al.
BJU International|December 14, 2023
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysisGiuseppe Ottone Cirulli, Nicholas Corsi, Ivan Rakic, et al.
The Journal of Urology|July 30, 2024
Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort AnalysisGiuseppe Ottone Cirulli, Matthew Davis, Alex Stephens, et al.
Pageof 5